Skip to content

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.

Published on

There's much ado about the gene-editing technique CRISPR/Cas9 this week, with a multinational summit in Washington, D.C. on human gene editing, plus the clock ticking …

Published on

A new study came out this week that happened to remind me of one of my pet peeves about certain biomedical studies -- choosing an …

How are drugs born? If you're really curious about this, you'd be fascinated by the weekly meetings of industry experts and academic researchers taking part …